vs
Side-by-side financial comparison of BIOMERICA INC (BMRA) and Qudian Inc. (HTT). Click either name above to swap in a different company.
BIOMERICA INC is the larger business by last-quarter revenue ($1.2M vs $1.1M, roughly 1.1× Qudian Inc.). Qudian Inc. runs the higher net margin — 239.8% vs -109.1%, a 348.9% gap on every dollar of revenue.
Biomerica Inc. is a global medical technology company that develops, manufactures and markets diagnostic test kits and related medical products. Its portfolio covers gastrointestinal conditions, infectious diseases, food intolerances and point-of-care testing solutions, serving clinical labs, healthcare providers and retail healthcare segments across North America, Europe and Asia.
Qudian Inc. is a China-based fintech service provider that mainly offers small consumer credit solutions, risk management technical services, and related digital financial products. Its core target users are young mass consumers across China, with all key business operations focused on the domestic Chinese market.
BMRA vs HTT — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $1.2M | $1.1M |
| Net Profit | $-1.3M | $2.6M |
| Gross Margin | 4.2% | 11.1% |
| Operating Margin | -113.5% | -121.7% |
| Net Margin | -109.1% | 239.8% |
| Revenue YoY | -26.0% | — |
| Net Profit YoY | -38.9% | — |
| EPS (diluted) | $-0.45 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2M | — | ||
| Q3 25 | $1.4M | — | ||
| Q1 25 | $1.1M | — | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $1.8M | $1.1M | ||
| Q2 24 | $1.1M | $1.0M | ||
| Q1 24 | $1.0M | $1.1M | ||
| Q4 23 | $1.6M | — |
| Q4 25 | $-1.3M | — | ||
| Q3 25 | $2.0K | — | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-950.0K | — | ||
| Q3 24 | $-1.3M | $2.6M | ||
| Q2 24 | $-1.4M | $1.9M | ||
| Q1 24 | $-1.9M | $-1.4M | ||
| Q4 23 | $-1.5M | — |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 30.7% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 26.7% | — | ||
| Q3 24 | 16.0% | 11.1% | ||
| Q2 24 | 2.1% | 13.3% | ||
| Q1 24 | -14.7% | — | ||
| Q4 23 | 20.7% | — |
| Q4 25 | -113.5% | — | ||
| Q3 25 | -81.0% | — | ||
| Q1 25 | -108.1% | — | ||
| Q4 24 | -60.7% | — | ||
| Q3 24 | -75.7% | -121.7% | ||
| Q2 24 | -136.6% | -107.6% | ||
| Q1 24 | -196.7% | -129.9% | ||
| Q4 23 | -102.6% | — |
| Q4 25 | -109.1% | — | ||
| Q3 25 | 0.1% | — | ||
| Q1 25 | -103.9% | — | ||
| Q4 24 | -58.1% | — | ||
| Q3 24 | -72.8% | 239.8% | ||
| Q2 24 | -127.1% | 187.1% | ||
| Q1 24 | -188.6% | -131.8% | ||
| Q4 23 | -96.2% | — |
| Q4 25 | $-0.45 | — | ||
| Q3 25 | $0.00 | — | ||
| Q1 25 | $-0.48 | — | ||
| Q4 24 | $-0.06 | — | ||
| Q3 24 | $-0.63 | $0.01 | ||
| Q2 24 | $-2.57 | $0.01 | ||
| Q1 24 | $-0.11 | $-0.01 | ||
| Q4 23 | $-0.09 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.5M | $104.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.4M | $225.2M |
| Total Assets | $6.0M | $246.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.5M | — | ||
| Q3 25 | $3.1M | — | ||
| Q1 25 | $3.1M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $2.8M | $104.9M | ||
| Q2 24 | $4.2M | $112.8M | ||
| Q1 24 | $5.3M | $140.6M | ||
| Q4 23 | $7.1M | — |
| Q4 25 | $4.4M | — | ||
| Q3 25 | $5.2M | — | ||
| Q1 25 | $5.5M | — | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $5.3M | $225.2M | ||
| Q2 24 | $6.6M | $217.5M | ||
| Q1 24 | $7.8M | $218.9M | ||
| Q4 23 | $9.4M | — |
| Q4 25 | $6.0M | — | ||
| Q3 25 | $6.9M | — | ||
| Q1 25 | $7.4M | — | ||
| Q4 24 | $7.3M | — | ||
| Q3 24 | $7.9M | $246.8M | ||
| Q2 24 | $9.3M | $227.9M | ||
| Q1 24 | $10.3M | $234.9M | ||
| Q4 23 | $11.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-991.0K | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-991.0K | — | ||
| Q3 25 | $-268.0K | — | ||
| Q1 25 | $-1.0M | — | ||
| Q4 24 | $-791.0K | — | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | $-1.0M | — | ||
| Q1 24 | $-1.8M | — | ||
| Q4 23 | $-842.0K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.1M | — | ||
| Q1 24 | — | — | ||
| Q4 23 | $-848.0K | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -95.5% | — | ||
| Q1 24 | — | — | ||
| Q4 23 | -54.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | 0.0% | — | ||
| Q4 23 | 0.4% | — |
| Q4 25 | — | — | ||
| Q3 25 | -134.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
